Adequate funding for a tech firm that specializes in biotechnology has reached an unprecedented level. De-extinction Inc., the company behind the pioneering work in reviving extinct species through genetic engineering, announced that it will seek new capital to propel forward its ambitious plans.
According to sources close to the company, Adequate funding for a tech firm that specializes in biotechnology has reached an unprecedented level. The de-extinction startup is reportedly looking to double or triple its previous valuation. This significant increase in investment could provide De-extinction Inc. with the necessary resources to further develop and scale up its technology.
The surge in interest in the biotech space, driven by advancements in genetic engineering and gene editing technologies, has attracted a plethora of new investors, including major firms and private equity houses. As De-extinction Inc. continues to push the boundaries of what is possible with genetic modification, it remains to be seen how this investment will impact its future endeavors and prospects for success.